Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events new depth article explores future patient reported outcomes pros
… Catherine Masaquel Market Access and Outcomes Strategy Medical Technologies Infectious Disease … CA MPH, Health Policy and Administration Yale University, New Haven, CT BS, Psychobiology University of California at … experience in market access and health economics and outcomes research. Ms. Masaquel’s therapeutic experience …
… Research, the Memorial Sloan-Kettering Cancer Center in New York, and the Catalan Institute of Oncology. Dr. Fortuny …
… Shannon Nelsen Market Access and Outcomes Strategy CNS/Neurology Headquarters - Research … (AMCP) dossiers, conducted literature reviews, implemented new dossier development processes, and developed slides and …
… and extensive experience in decision-analytic modeling, patient-reported outcomes and statistical analysis. Dr. Basarir has been …
… 30 years of experience conducting health economics and outcomes research, including 5 years in the Global Health … in the hands of marketplace decision makers, facilitating patient access to valuable new health care technologies. Ms. Mladsi’s training is in …
… US. In a recent study, the majority of payers interviewed reported they would use an ICER cost-effectiveness threshold …
Romin Pajouheshnia Pharmacoepidemiology and Risk Management PhD, Epidemiology MSc, Epidemiology / Medical Statistics Utrecht University, Utrecht, Netherlands BA, Natural Sciences / Pathology University of Cambridge, Cambridge, United Kingdom University …
… study and withdraw your consent, we will stop collecting new Personal Data from you. Please note that once your data …
… of Public Health, Baltimore, DE BS, Business and Finance New York University, Shanghai, China Lola (Ziyi) Xiao, MHS, is a Health Outcomes Scientist at RTI-HS. Ms. Xiao has an academic …
… form to the right. Learn more about our market access and outcomes strategy expertise . Q. If a GVD is to support a … may be different (e.g. non-comparative studies with low patient numbers are more acceptable) compared with non-orphan …